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Most tissues are patterned so that progenitors in different locations are programmed to have different properties. Stem cells from different
regions of the nervous system acquire intrinsic differences in their properties as they migrate through distinct environments. Hematopoietic
stem cells (HSCs) also migrate through diverse environments throughout life, raising the question of whether HSCs also acquire at least
transient changes in their properties as they are exposed to diverse environments. Although we observed significant differences in
hematopoiesis between the fetal liver and fetal spleen, we were not able to detect phenotypic, functional, or gene expression differences
between the HSCs in these organs. Regional differences in definitive hematopoiesis are therefore not determined by regional differences
between HSCs. We were also not able to detect phenotypic, functional, or gene expression differences between HSCs in different adult bone
marrow compartments. Our failure to detect differences among stem cells from different regions of the hematopoietic system at the same time
during development suggests that the hematopoietic system has evolved mechanisms to prevent the spatial reprogramming of HSC properties
as they migrate between distinct environments.
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Many tissues are distributed throughout the body and
require considerable stem cell migration to generate diverse
types of mature cells in diverse locations. One mechanism
by which many tissues regulate the generation of different
cell types in different locations is by patterning stem cells to
acquire regional identities (Abrams et al., 2003; Alvares et
al., 2003; Mikawa et al., 2004; Niswander, 2003). That is,
the cell-intrinsic properties of stem cells are modified in
response to environmental signals. This allows stem cells in
different locations to acquire distinct regional identities and
properties as they migrate through different environments.
As an example, neural crest stem cells from different levels0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.03.037
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E-mail address: seanjm@umich.edu (S.J. Morrison).of the neural tube are patterned to have different regional
identities (Bixby et al., 2002). Neural crest cells are
patterned partly by the signals they encounter during
migration (Trainor et al., 2002). Regional identities in
neural progenitors are marked by differences in gene
expression (Trainor and Krumlauf, 2001), migration (De
Bellard et al., 2003; Natarajan et al., 2002), and sensitivity
to differentiation cues (Bixby et al., 2002). These differ-
ences cause neural crest stem cells in different locations to
acquire different fates despite having similar development
potentials (Bixby et al., 2002).
A fundamental question is whether different tissues
exhibit different strategies by which they generate spatial
diversity from stem cells. Both the nervous and hemato-
poietic systems are distributed throughout the body,
generate new cells in diverse locations, and localize differ-
ent types of mature cells in different places. Neural stem
cells are segregated among different regions of the devel-283 (2005) 29 – 39
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peripheral nervous system (Bixby et al., 2002; Kruger et al.,
2002). Hematopoietic stem cells (HSCs) are segregated
among different fetal organs and adult bone marrow
compartments. This raises the question of whether HSCs,
like neural stem cells, acquire spatial differences in their
properties as they reside in or migrate through distinct
environments in different parts of the body. Stem cells from
these tissues exhibit strong similarities in other ways, as
neural crest stem cells from the gut undergo temporal
changes in developmental potential, mitotic activity, and
self-renewal potential that are similar to the temporal
changes observed in HSCs (Kruger et al., 2002; Morrison
et al., 1996).
The fact that adult HSCs recirculate regularly among
different hematopoietic compartments (Wright et al., 2001)
suggests that HSCs must not acquire permanent regional
differences in their properties that irreversibly restrict them
to certain hematopoietic compartments. However, this does
not address the question of whether these cells undergo at
least transient changes in their properties while residing in
or migrating through distinct hematopoietic compartments.
It is conceivable that HSCs in different regions of the
hematopoietic system exhibit transient changes in gene
expression that cause transient changes in their response to
factors that regulate differentiation or migration. Such
changes would have important consequences for the
mechanisms that regulate homeostasis in hematopoiesis.
Definitive hematopoiesis first arises in the mouse fetal
liver at embryonic day 10 (E10) where it continues
throughout fetal development (Medvinsky, 1993). In late
gestation, hematopoiesis expands into the spleen and then
the bone marrow. Definitive hematopoiesis is simultane-
ously active in two different locations in the late gestation
liver and spleen. It is unknown whether there are differences
in hematopoiesis between the fetal liver and fetal spleen, or
whether there are intrinsic differences between HSCs in
these organs. Adult hematopoiesis is segregated among
many different bone marrow compartments. It has not been
carefully tested whether HSCs from distinct bone marrow
compartments differ in function or gene expression.
To address this question, we isolated HSCs from the fetal
liver and fetal spleen, or from different adult bone marrow
compartments and compared their phenotype, function, and
gene expression profiles. We were not able to detect any
significant differences between HSCs from fetal liver and
fetal spleen, despite detecting differences in hematopoiesis
from those two locations. We were also unable to detect any
differences among HSCs from different adult bone marrow
compartments. This indicates that the hematopoietic system
must employ mechanisms that prevent HSCs from under-
going changes in their properties in distinct hematopoietic
compartments or during their migration between compart-
ments. The hematopoietic system is remarkably different
from other tissues in its avoidance of regional diversification
in stem cells.Materials and methods
All mice used in this study were housed by the Unit for
Laboratory Animal Medicine at the University of Michigan.
Timed pregnant females were used for the isolation of fetal
cells and HSCs. Adult (6–8 weeks old) C57BL/6:Ka-
Thy1.1 (CD45.2) were used for the isolation and character-
ization of whole bone marrow and HSCs. Recipient mice in
long-term competitive reconstitution assays were 8+-week-
old C57BL/6:Ka-CD45.1 (Thy-1.2) mice.
Flow-cytometric isolation of HSCs
To obtain fetal hematopoietic cells, timed pregnant
females were sacrificed 18 (E18.5) days after the morning
on which a vaginal plug was observed. The liver and spleen
from individual pups were dissected into HBSS without
calcium or magnesium, supplemented with 2% heat-
inactivated calf serum (HBSS+; Gibco, Grand Island NY).
Adult hematopoietic cells were obtained from 6- to 8-week-
old C57BL/6:Ka-Thy1.1 mice. Bones were dissected and
overlying blood vessels, muscle, and fascia were thoroughly
excised before flushing each marrow cavity with HBSS+.
Fetal and adult cells were triturated into single-cell
suspensions and filtered through nylon screen (45 Am,
Sefar America, Kansas City, MO). For HSC staining, cells
were incubated with a panel of unconjugated monoclonal
antibodies to lineage markers including B220 (6B2), CD3
(KT31.1), CD5 (53-7.3), CD8 (53-6.7), Gr-1 (8C5), and
Ter119 (Ly76). The cells were washed and resuspended in
anti-rat IgG F(ab)2 fragment conjugated to phycoerythrin
(PE) (Jackson ImmunoResearch, West Grove, PA). Adult
marrow cells were subsequently stained with directly
conjugated antibodies to Sca-1 (E13-APC), c-kit (2B8-
biotin), Thy-1.1 (19EX5-FITC), Mac-1 (M1/70-PE), and
CD4 (GK1.5-PE). Fetal cells were stained with directly
conjugated antibodies to Sca-1 (E13-biotin), Thy-1.1
(19EX5-FITC), Mac-1 (M1/70-APC), and CD4 (GK1.5-
PE). Streptavidin-PharRed (APC-Cy7) was used to visualize
biotinylated antibodies. In some experiments on fetal HSCs,
CD48 (BCM1-PE; Pharmingen, San Diego) was also added
to the lineage cocktail. HSCs were often pre-enriched by
selecting for Sca-1+ or c-kit+ cells with Miltenyi autoMACS
magnetic microbeads (Miltenyi Biotec, Auburn CA). Cells
were resuspended in 2 Ag/ml 7-AAD (Molecular Probes,
Eugene, OR) to discriminate live from dead cells. Adult
HSCs were sorted on a FACS Vantage (Becton-Dickinson,
San Jose, CA) as Thy-1lowSca-1+Lineagec-kit+ (with Mac-
1 in the lineage cocktail) whereas fetal HSCs were sorted as
Thy-1lowSca-1+LineageMac-1+ (with CD48 for functional
and PCR studies).
Methylcellulose culture
Unfractionated cells or individual HSCs were plated in
the wells of a 96-well plate (Corning, Corning NY)
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Technologies, Vancouver, BC) containing 20% charcoal-
absorbed fetal bovine serum (Cocalico, Reamstown PA), 1%
BSA (Sigma). Cultures assessing colony-forming progeni-
tors (CFUs) were supplemented with 50 ng/ml stem cell
factor (SCF), 10 ng/ml interleukin-3 (IL-3), 10 ng/ml
interleukin-6 (IL-6), and 3 U/ml erythropoietin (Epo). For
HSC methylcellulose cultures, 10 ng/ml Flt-3 and 10 ng/ml
thrombopoietin (Tpo) were also added to the culture
medium. Cultures assessing pre-B content were performed
using IL-7 and SCF (Stem Cell Technologies, Inc.). All
cytokines except IL-7 were obtained from R&D Systems
(Minneapolis, MN). Cultures were maintained in tissue
culture incubators at 37-C in 6.5% CO2 and scored after
10–14 days.
Long-term competitive reconstitution analysis
Long-term competitive reconstitution assays were per-
formed as previously described (Morrison and Weissman,
1994). Briefly, adult CD45.1+ mice (>8 weeks old) were
lethally irradiated with a Cobalt source delivering approx-
imately 75 rad/min. The mice were administered two doses
of 570 rad each, delivered at least 3 h apart. CD45.2+ HSCs
were sorted and then resorted into individual wells of a 96-
well plate containing 2  105 CD45.1+ whole bone marrow
cells. The contents of individual wells were injected into the
retro-orbital venous sinus of anesthetized CD45.1+ recipi-
ents. Mice were maintained on antibiotic water (1.1 g
neomycin sulfate and 106 U/l polymixin B sulfate; Sigma).
After 4–16 weeks, blood was obtained from the tail veins of
recipients, subjected to ammonium-chloride red cell lysis,
and analyzed to determine the level of donor reconstitution.
Gene expression profiling of HSCs
Three independent aliquots of 2000 resorted HSCs
isolated from the adult femur, pelvis, or sternum or from
the E18.5 spleen or liver were directly sorted into 400 Al
Trizol (Ambion, Austin, TX) containing 250 Ag/ml glyco-
gen (Roche, Indianapolis, IN). RNA was extracted accord-
ing to the manufacturer’s instructions. The extracted RNA
(30 Al volume) was treated for 20 min at 37-C with 2 Al
RNase-free DNaseI (2 U/Al; Ambion) in the presence of 2 Al
RNase inhibitor (10 U/Al; Invitrogen). The RNA was then
purified using an RNeasy Mini Kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. Two consec-
utive rounds of RNA amplification and then probe hybrid-
ization were performed as described (Iwashita et al., 2003)
(see Supplementary material in Appendix A for details).
After fragmentation (Mahadevappa and Warrington,
1999), 10 Ag of cRNA was hybridized per chip to Mouse
U74 whole genome chip A (Affymetrix). The chips were
hybridized and scanned according to the manufacturer’s
instructions. Signal intensities were read and processed for
analysis as described previously (Iwashita et al., 2003). Tomeasure fold-changes between the two populations, we set
all signal intensities less than 100 to 100. To calculate the
Pearson’s correlation coefficient (R2) between any two
groups, we transformed each value to the base 10 logarithm
(log10) using the formula log10(max(X + 100, 0) + 100).
Note that log10 transformation is required because Pearson’s
correlation coefficient is designed to be calculated based on
normally distributed data, and the untransformed data are
not normally distributed (Glantz, 1992). Although more
statistically appropriate, the calculation of correlation
coefficients based on log10 transformed data causes these
R2 values to be lower than they would be if calculated based
on untransformed data. The statistical significance of
differences in signal intensity for each probe set were
evaluated by t test using the log10 transformed values from 3
independent replicates for each cell population.
To evaluate whether gene expression profiles from
samples of different cell types were significantly more
variable than from samples of the same cell type, we
calculated R2 values for all of the pairwise combinations of
samples of different cell types and then tested whether these
R2 values were significantly different by t test from the
pairwise combinations of R2 values between samples of the
same cell type. Differences in expression were independ-
ently tested by quantitative (real-time) RT-PCR (qRT-PCR).
Quantitative real time-PCR (qRT-PCR)
Total RNA of HSCs was extracted as above and treated
with DNaseI. After purification of the RNA (RNeasy Mini
Kit), cDNAwas prepared by reverse transcription with 1 Ag
random hexamer. The cDNA was extracted with phenol-
chloroform and precipitated with 20 Ag glycogen. After
dissolving the cDNA with RNase-free water, cDNA
equivalent to 200 HSCs was used for each PCR reaction.
qRT-PCR was performed in triplicate using independent cell
samples. Primers were designed to have a Tm of ¨59-C and
to generate short amplicons (100–150 bp). The PCR
reactions were performed using a LightCycler (Roche
Diagnostic Corp.) according to the manufacturer’s instruc-
tions. Control reactions were performed after omitting
reverse transcriptase from the cDNA reaction. The RNA
content of samples compared by qRT-PCR was normalized
based on the amplification of HPRT. qRT-PCR products
were separated in 2% agarose gels to confirm the presence
of a single band of the expected size.Results
Spatial differences in hematopoiesis between the E18 liver
and spleen
Just as distinct types of cells are generated in differing
proportions in different regions of the developing nervous
system, we also observed differences in hematopoiesis
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significantly more Ter119+ erythroid progenitors and B220+
B-lineage cells while the E18.5 spleen had significantly
more Mac-1+ or Gr-1+ myeloid lineage cells, and
CD41+CD61+ megakaryocyte lineage cells (Fig. 1; P <
0.05). There was no significant difference in the frequency
of c-kit+ progenitor cells. To directly assess whether these
differences were associated with differences in the fre-
quency of colony-forming progenitors, we cultured unfrac-
tionated E18.5 liver or spleen cells in methylcellulose and
counted the frequency of progenitors that formed various
types of colonies. Consistent with the results above, the liver
contained a significantly higher frequency of erythroid
(BFU-E; burst-forming unit-erythroid) and B lineage
progenitors (CFU-pre-B; colony-forming unit-pre-B), while
the spleen contained a significantly higher frequency of
myeloid lineage progenitors (CFU-GM; colony-forming
unit-granulocyte, macrophage) and megakaryocyte progen-
itors (CFU-Meg; colony-forming unit-megakaryocyte).
There was no significant difference in the frequency of
more primitive myeloerythroid progenitors (CFU-GEMM;
colony-forming unit-granulocyte, erythroid, macrophage,Fig. 1. Differences in hematopoiesis between the E18.5 liver and the E18.5
spleen. (A) The fetal liver contained significantly (*P < 0.05) higher
frequencies of Ter119+ erythroid progenitors and B220+ B-lineage cells
whereas the spleen contained significantly higher frequencies of Mac-1+ or
Gr-1+ myeloid lineage cells and CD41+CD61+ megakaryocytes. There was
no difference in the frequency of c-kit+ progenitors. (B) The fetal liver also
contained a higher frequency of BFU-E erythroid progenitors, and CFU-
pre-B progenitors. The spleen contained a significantly higher frequency of
CFU-GM myeloid progenitors and CFU-Meg megakaryocyte progenitors,
but the difference in myeloerythroid progenitors (CFU-GEMM) was not
statistically significant. The data were based on 9 (A) or 10 (B) independent
experiments. Error bars represent SD. Differences were evaluated by
homoscidastic (A) or paired (B) t tests.megakaryocyte). These results indicate that there are spatial
differences in fetal definitive hematopoiesis.
HSCs from the E18 liver and spleen have similar
phenotypes and functions
If the hematopoietic system employs a similar strategy as
the nervous system for generating spatial diversity from
stem cells, then splenic HSCs should preferentially adopt
myeloid fates, and liver HSCs should preferentially adopt
lymphoid and erythroid fates. Alternatively, the HSCs might
not be intrinsically different, but the environments might
favor the increased generation of lymphoid and erythroid
cells in the liver and myeloid cells and megakaryocytes in
the spleen. HSCs can be prospectively identified and
isolated by flow-cytometry from the fetal liver as Thy-
1lowSca-1+LineageMac-1+ cells (Morrison et al., 1995).
Phenotypically indistinguishable Thy-1lowSca-1+Linea-
geMac-1+ cells existed in both organs at similar frequen-
cies (Suppl. Fig. 1 in Appendix A; 0.0095 T 0.0029% in
E18.5 spleen and 0.0073 T 0.0040% in E18.5 liver; P =
0.38). To compare their functions, we performed compet-
itive long-term reconstitution assays in which 5 CD45.2+
Thy-1lowSca-1+LineageMac-1+ cells from the E18.5 liver
or spleen were injected into lethally irradiated CD45.1+
mice along with a radioprotective dose of 200,000 CD45.1+
whole bone marrow cells. Table 1 shows that the Thy-
1lowSca-1+LineageMac-1+ populations from the E18.5
liver and spleen were similarly highly enriched for HSC
activity and were functionally indistinguishable in this
assay. Based on limit-dilution statistics (Smith et al.,
1991), 1 out of every 5.1 intravenously injected cells from
either population detectably reconstituted, and around 87%
of the reconstituted mice were long-term multilineage
reconstituted by donor cells. At 16 weeks after reconstitu-
tion, there was no difference in the level of donor myeloid,
B, or T cell engraftment from either HSC population. This
indicates that there was no difference in the propensity of
fetal liver and fetal spleen HSCs to form myeloid or
lymphoid cells in the reconstitution assay, despite the
differences in myelopoiesis and lymphopoiesis observed in
the fetal liver and fetal spleen (Fig. 1).
To test whether these HSCs exhibit biases in the types of
restricted progenitors they form, we sorted individual E18.5
liver or spleen Thy-1lowSca-1+LineageMac-1+ cells into
methylcellulose cultures supplemented with IL-3, IL-6,
SCF, Flt-3, thrombopoietin, and erythropoietin. There was
no difference in the frequency of cells that formed colonies
(88–90%) or in the types of colonies they formed (Table
2A). To directly assess lineage commitment within these
colonies, we subcloned individual CFU-GEMM colonies
into secondary methylcellulose cultures to determine
whether there was any difference between liver and spleen
HSCs in the extent to which they gave rise to myeloid or
erythroid progenitors in culture. There was no significant
difference in the total number of secondary colonies, or in
Table 1
Thy-1lowSca-1+LineageMac-1+ cells from the E18.5 liver and spleen are highly enriched for HSC activity, and indistinguishable in long-term competitive
reconstitution assays
Fetal HSC
population
Mice that
engrafted
Frequency of
cells that engrafted
Long-term multilineage
reconstituted mice
Donor CD3+
T cells
Donor Mac-1+
myeloid cells
Donor B220+
B cells
Spleen 67% (14/21) 1 in 5.1 86% (12/14) 27 T 22% 47 T 29% 33 T 34%
Liver 67% (16/24) 1 in 5.1 87% (14/16) 21 T 24% 50 T 30% 38 T 31%
CD45.1+ recipient mice were lethally irradiated and competitively reconstituted with 5 CD45.2+ donor Thy-1lowSca-1+LineageMac-1+ cells from either the
E18.5 liver or spleen. The frequency of donor cells that engrafted was calculated based on Poisson limit-dilution statistics (Smith et al., 1991). The frequency of
donor-type myeloid, B, and T cells was determined as a percentage of all myeloid, B, and T cells in long-term multilineage reconstituted mice 16 weeks after
reconstitution. The data are based on two independent experiments. No differences were statistically significant.
M.J. Kiel et al. / Developmental Biology 283 (2005) 29–39 33the numbers of secondary CFU-GM, BFU-E, or CFU-
GEMM colonies generated per subcloned CFU-GEMM
colony (Table 2B). There was no intrinsic difference
between fetal liver and fetal spleen HSCs in the extent to
which they generate myeloid and erythroid progenitors in
culture.
Fetal spleen HSCs and fetal liver HSCs have very similar
gene expression profiles
To rigorously test for differences between spatially
distinct HSCs, we compared the gene expression profiles
of E18.5 liver and spleen Thy-1lowSca-1+LineageMac-1+
HSCs using methods we have described previously (Iwa-
shita et al., 2003). We did this using oligonucleotide arrays
that contain 12,422 probe sets, and compared both overall
gene expression profiles using Pearson’s correlation coef-
ficients, as well as numbers of differentially expressed
genes. Genes were considered differentially expressed if
there was more than a 3-fold difference in average signal
intensity, the pairwise comparisons of replicate samples
each were at least 2.5-fold different, the 3 replicate samples
of each cell type were significantly different (P < 0.01), and
signal intensity was above background (present call) in at
least 2 of 3 samples from one cell population. We have used
similar criteria to identify genes differentially expressedTable 2
Single Thy-1lowSca-1+LineageMac-1+ cells from the E18.5 liver and spleen f
cultures
(A) Primary colonies
Fetal HSC
population
Cells that
formed colonies
CFU-GEMM
colonies
C
c
Spleen 88 T 4.7% 26 T 3.8% 6
Liver 90 T 2.4% 27 T 5.0% 6
(B) Secondary colonies
Fetal HSC
population
Total secondary
colonies
Secondary
CFU-GM colonies
S
B
Spleen 1620 T 590 1590 T 330 1
Liver 1460 T 180 1440 T 310 1
Thy-1lowSca-1+LineageMac-1+ cells were sorted into methylcellulose (1 cell/wel
formed (A). Individual CFU-GEMM colonies were then subcloned after 12 day
secondary colonies, as well as the total number of CFU-GM, BFU-E, and CFU-GE
Secondary CFU-Meg colonies could not be reliably identified in the secondary c
statistically significant.among stem cells in previous studies because less stringent
criteria include a high frequency of false-positives that fail
to confirm using independent techniques/samples (Iwashita
et al., 2003; Molofsky et al., 2003). We readily observed
differences between E18.5 liver HSCs and E18.5 liver
CD45+ cells (squared Pearson’s correlation coefficient, R2 =
0.808; 450 differentially expressed genes) and between
E18.5 spleen HSCs and E18.5 liver CD45+ cells (R2 =
0.833; 334 differentially expressed genes) (Table 3).
However, we were unable to detect differences in gene
expression between fetal liver HSCs and fetal spleen HSCs
(R2 = 0.966; 8 differentially expressed genes) beyond what
was observed among replicate samples of the same type
(variation among fetal liver HSC samples R2 = 0.961).
Variation in gene expression between fetal liver HSCs and
fetal spleen HSCs was thus similar to the variation observed
among the fetal liver HSC samples.
The 8 genes that appeared to be differentially expressed
between fetal liver HSCs and fetal spleen HSCs by
microarray analysis were all expressed at higher levels in
fetal spleen samples and were all genes that are expressed
by mature mast cells or mature erythrocytes (Suppl. Table 1
in Appendix A). This suggested that the fetal spleen HSCs
were slightly contaminated by differentiated cells. In an
effort to identify new markers that would facilitate improved
purification, we discovered that CD48 is expressed by manyorm indistinguishable primary and secondary colonies in methylcellulose
FU-GM
olonies
CFU-Meg
colonies
BFU-E
colonies
7 T 4.0% 5.4 T 2.6% 2.1 T 2.6%
6 T 4.3% 5.2 T 1.4% 1.7 T 0.6%
econdary
FU-E colonies
Secondary CFU-GEMM
colonies
8.1 T 8.0 10.6 T 1.3
6.6 T 17.6 12.4 T 1.1
l) to determine the rate of colony formation, and the types of colonies they
s in culture into secondary methylcellulose cultures. The total number of
MM colonies generated per subcloned CFU-GEMM colony are shown (B).
ultures. The data represent 3 independent experiments, no differences were
Table 3
Spatially distinct HSCs exhibit similar gene expression profiles, while temporally distinct HSCs exhibit clear differences in gene expression profiles
Fetal spleen
HSCs
Fetal liver
CD45+ cells
Adult femur
HSCs
Adult pelvis
HSCs
Adult sternum
HSCs
Adult femur
CD45+
Fetal liver HSCs 0.966* (11) 0.808 (450) 0.909 (116) 0.899 (106) 0.892 (123) 0.749 (665)
Fetal spleen HSCs 0.833 (334) 0.900 (133) 0.898 (118) 0.890 (134) 0.767 (599)
Fetal liver CD45+ cells 0.761 (533) 0.782 (386) 0.774 (416) 0.856 (235)
Adult femur HSCs 0.959* (1) 0.958* (1) 0.724 (710)
Adult pelvis HSCs 0.963* (1) 0.732 (593)
Adult sternum HSCs 0.726 (587)
Each cell within the table shows the squared Pearson’s correlation coefficient (R2 values) between mean signal intensities for the 3 samples of each cell type,
along with the number of differentially expressed probe sets in parentheses. These results are based on an interrogation of 12,422 probe sets. Samples of
different types that did not show significantly more variability ( P > 0.05 by t test) than observed among samples of the same type (when all pairwise
combinations of replicate samples were considered; see Materials and methods) are indicated (*).
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erythroid cells, but not by HSCs (note that all functional
studies on fetal HSCs employed CD48 cells, but the cells
used in the initial microarray analysis were not selected
based on CD48 expression). When CD48 was included in
the lineage cocktail to eliminate these mature cells, none of
these genes remained differentially expressed between fetal
liver and fetal spleen HSCs by quantitative RT-PCR (Suppl.
Table 1 in Appendix A). Even when the standards for
differential expression were lowered to include only a 2-fold
change in average signal intensity, only 1 additional gene
appeared to be differentially expressed by microarray
analysis (data not shown). Thus, we were unable to identify
significant numbers of genes that were differentially
expressed between fetal liver and spleen HSCs.
Hematopoiesis is similar in different adult bone marrow
compartments
In the adult hematopoietic system, different types of
progenitors are present in different locations within the bone
marrow (Calvi et al., 2003; Nilsson et al., 2001; Zhang et
al., 2003). Moreover, different types of progenitors appear
to associate with different types of stromal cells, and these
stromal cells localize to anatomically distinct regions within
the bone (Calvi et al., 2003; Zhang et al., 2003). Different
bones have different shapes, different proportions of
trabecular bone, and different ratios of endosteal marrow
to central marrow. This raises the question of whether there
are differences in hematopoiesis between different bones.
Indeed, the rate of erythropoiesis has been observed to vary
between bones in a way that is different from lymphopoiesis
or total cellularity (Vacha et al., 1982). To our knowledge,
HSCs from different bone marrow compartments have never
been carefully compared to test whether they exhibit
intrinsic differences.
We analyzed the proportions of CD3+ T cells, B220+ or
surface (s)IgM+ B cells, Ter119+ erythroid cells, and Mac-1+
or Gr-1+ myeloid cells in bone marrow cells from the
calvarium, femur, humerus, pelvis, scapula, sternum, and
tibia. The calvarium had a significantly (P < 0.05) higher
proportion of CD3+ cells and the scapula had a significantlylower proportion of Ter119+ erythroid cells relative to other
bones but we did not observe any other differences that
were statistically significant (Fig. 2). There were also no
statistically significant differences in the frequency of
Thy-1lowSca-1+Lineagec-kit+ HSCs, Thy-1lowSca-1+Mac-
1lowCD4low non-self-renewing multipotent progenitors
(Morrison and Weissman, 1994; Morrison et al., 1997),
CFU-GEMM, BFU-E, CFU-GM, or CFU-Meg between
the different bone marrow compartments (Fig. 2). These
data suggest that if there are differences in hematopoiesis
between different bone marrow compartments, they are
subtle, or only detectable using other assays.
HSCs from different adult bone marrow compartments have
similar functional properties
Neural stem cells that persist throughout adult life in
different regions of the central (Doetsch et al., 1999;
Johansson et al., 1999; Palmer et al., 1997) and peripheral
nervous systems (Kruger et al., 2002) continue to have
different properties. To compare the functional properties
of adult HSCs, we isolated Thy-1lowSca-1+Lineagec-kit+
cells from the femur, pelvis, and sternum of 6- to 8-week-
old adult mice (Suppl. Fig. 2 in Appendix A). The Thy-
1lowSca-1+Lineagec-kit+ population contains all of the
HSC activity that we have been able to detect in adult bone
marrow (Morrison and Weissman, 1994; Spangrude et al.,
1988; Uchida and Weissman, 1992). These HSC populations
did not differ in the proportion of cells that formed colonies
in methylcellulose (91–96%) or in the types of colonies
they formed (Suppl. Table 2 in Appendix A). They also
did not differ in their performance in long-term compet-
itive reconstitution assays in which lethally irradiated mice
were injected with 4 Thy-1lowSca-1+Lineagec-kit+ cells
from the femur, pelvis, or sternum (Table 4). In each case,
1 out of every 3.4 to 4.2 intravenously injected donor cells
detectably reconstituted and 75 to 83% of the mice that
were reconstituted by donor cells became long-term
multilineage reconstituted. Although the level of recon-
stitution tended to be lower from sternum HSCs, the
differences were not statistically significant because of
high variability between mice in all treatments. We were
Fig. 2. Hematopoiesis is very similar between different adult mouse bone
marrow compartments. Whole bone marrow cells were extracted from the
calvarium, femur, humerus, pelvis, scapula, sternum, and tibia of 6- to 8-
week-old mice. (A) The frequencies of CD3+ T cells, B220+ or sIgM+ B
cells, Ter119+ erythroid cells, and Mac-1+ or Gr-1+ myeloid cells were
compared by flow-cytometry. The calvarium had a significantly (*P < 0.05)
higher proportion of CD3+ cells and the scapula had a significantly lower
proportion of Ter119+ cells relative to other bones. (B) The frequencies of
Thy-1lowSca-1+Lineagec-kit+ HSCs, Thy-1lowSca-1+Mac-1lowCD4low
non-self-renewing multipotent progenitors (Morrison et al., 1997; Morrison
and Weissman, 1994) and (C) CFU-GEMM, BFU-E, CFU-GM, and CFU-
Meg did not differ between bones. The data represent 5 (A), 6 (B), and 3
(C) independent experiments.
M.J. Kiel et al. / Developmental Biology 283 (2005) 29–39 35unable to detect any functional differences in vitro or in
vivo between adult HSCs from different bone marrow
compartments.
HSCs from different adult marrow compartments have
similar gene expression profiles
To test for differences in the gene expression profiles of
HSCs from different adult bone marrow compartments, we
compared Thy-1lowSca-1+Lineagec-kit+ HSCs from the
femur, pelvis, and sternum using the methods and criteriadescribed above. We readily observed differences in gene
expression between adult HSCs and CD45+ cells (R2 =
0.724 to 732; 587 to 710 differentially expressed genes,
depending on the comparison; Table 3). However, we were
unable to detect differences in gene expression between
HSCs from different bone marrow compartments (R2 =
0.958 to 0.963; 3 differentially expressed genes, Table 3)
beyond the variability observed among HSCs isolated from
the same bone (data not shown). qRT-PCR failed to confirm
the differential expression of any of the 3 genes that
appeared to be differentially expressed by microarray
analysis between HSC populations (Suppl. Table 1 in
Appendix A). Even when the standards for differential
expression were lowered to include only a 2-fold change in
average signal intensity, only 4 additional genes appeared to
be differentially expressed by microarray analysis. Thus, we
were unable to identify significant numbers of genes that
were differentially expressed among spatially distinct adult
HSC populations.
Cluster analysis also found that the variability among
samples from the same bones was similar to the variability
among samples from different bones (Fig. 3). This cluster
analysis complements our analysis of the numbers of
differentially expressed genes, because even subtle differ-
ences in gene expression could affect clustering. This
demonstrates that spatially distinct HSC populations could
not have exhibited even subtle differences in gene expres-
sion that were consistent. We were thus unable to identify
any significant differences in gene expression between
HSCs from different adult bone marrow compartments.
Temporal changes in HSC gene expression
Even though we could detect no differences among
spatially distinct HSCs at the same times during develop-
ment, HSC gene expression (Ivanova et al., 2002; Phillips et
al., 2000) and function (Harrison et al., 1997; Ikuta et al.,
1990; Kantor et al., 1992; Morrison et al., 1995) have been
observed to change over time. Consistent with this, we
observed significantly (P < 0.001) lower R2 values when
we compared fetal HSCs to adult HSCs (R2 = 0.890 to
0.909; 106 to 134 differentially expressed genes) as
compared to when we compared spatially distinct fetal
(R2 = 0.966) or adult (R2 = 0.958–963) HSCs. Consistent
with prior studies, we were therefore readily able to
identify differences in gene expression between temporally
distinct HSCs.
Using the same criteria as we had used to look for genes
that were differentially expressed among spatially distinct
HSCs, we identified genes that were more highly expressed
in fetal liver HSCs as compared to adult bone marrow
HSCs. When these criteria included 3-fold higher expres-
sion level, we identified 26 genes that were upregulated in
fetal liver HSCs (Suppl. Table 3 in Appendix A), but when
these criteria were relaxed to include 2-fold higher
expression, the number of genes increased to 70. To validate
Table 4
Thy-1lowSca-1+Lineagec-kit+ HSCs from the adult mouse femur, pelvis, or sternum did not significantly differ in their ability to give long-term multilineage
reconstitution in competitive reconstitution assays
Adult HSC
population
Mice that
engrafted
Frequency of
cells that engrafted
Long-term multilineage
reconstituted mice
Donor Mac-1+
myeloid cells
Donor B220+
B cells
Donor CD3+
T cells
Femur 71% (10/14) 1 in 3.7 80% (8/10) 32 T 38% 23 T 23% 4 T 5%
Pelvis 67% (8/12) 1 in 4.2 75% (6/8) 34 T 17% 32 T 33% 14 T 21%
Sternum 75% (6/8) 1 in 3.4 83% (5/6) 16 T 32% 17 T 33% 2 T 4%
Four CD45.2+ Thy-1lowSca-1+Lineagec-kit+ cells from the femur, pelvis, or sternum of 6- to 8-week-old mice were injected along with 200,000 CD45.1+ cells
into lethally irradiated CD45.1+ mice. The frequency of cells that engrafted with donor cells was calculated based on Poisson limit-dilution statistics (Smith et
al., 1991). The frequency of donor-type myeloid, B, and T cells was determined as a percentage of all myeloid, B, and T cells in long-term multilineage
reconstituted mice 30 weeks after reconstitution. A second experiment using 5 donor cells from either adult HSC population per recipient gave similar results.
No differences were statistically significant.
M.J. Kiel et al. / Developmental Biology 283 (2005) 29–3936these differences, we compared the expression of 17 of these
genes by qRT-PCR and confirmed that 14 were differ-
entially expressed in independent samples (5 of these genes
are shown on Suppl. Table 3 in Appendix A). A number of
the most highly differentially expressed genes related to Igf2
expression or function, including H19 (a gene that regulates
Igf2 expression), Igf2 itself, and the gene that encodes Igf2
binding protein 1 (Suppl. Table 3 in Appendix A). This is
consistent with prior studies showing that Igf2 is more
highly expressed in fetal than in adult tissues (Lee et al.,
1990). Given that Igf2 can promote an expansion of fetal
liver HSCs in culture (Zhang and Lodish, 2004), this
pathway could regulate physiological differences in self-
renewal/mitotic activity between fetal and adult HSCs. Gfi-Fig. 3. Cluster analysis indicates that spatially distinct HSCs exhibit similar
gene expression profiles, while temporally distinct HSCs exhibit differences
in gene expression profiles. Cluster analysis was not able to detect any
consistent differences among adult HSCs from different bone marrow
compartments, or among fetal HSCs from the liver and spleen. However,
the adult HSCs were consistently grouped as being different from the fetal
HSCs, CD45+ fetal hematopoietic cells, or CD45+ adult hematopoietic
cells. This analysis was performed using ‘‘Cluster’’ software (http://
rana.lbl.gov/EisenSoftware.htm) (Eisen et al., 1998).1, a gene that regulates the proliferation of adult HSCs
(Hock et al., 2004), was also more highly expressed in fetal
liver HSCs, raising the possibility that this gene also
regulates fetal liver HSC proliferation. These differences
in gene expression raise interesting hypotheses regarding
mechanisms that might control differences in self-renewal
potential and mitotic activity between fetal and adult HSCs,
though such hypotheses will have to be tested in knockout
mice.Discussion
These data represent the first comprehensive comparison
of HSCs from different hematopoietic compartments.
Despite observing differences in hematopoiesis between
the fetal liver and fetal spleen (Fig. 1), we were unable to
detect any differences between fetal liver HSCs and fetal
spleen HSCs in terms of frequency, phenotype (Suppl. Fig.
1 in Appendix A), ability to reconstitute irradiated mice
(Table 1), colony formation in culture (Table 2A), gen-
eration of colony-forming progenitors in culture (Table 2B),
or gene expression profile (Table 3; Suppl. Table 1 in
Appendix A). When comparing different adult bone marrow
compartments, we detected subtle differences in the
frequency of CD3+ T cells and Ter119+ erythroid progen-
itors (Fig. 2). However, we were unable to detect any
differences in the frequency of HSCs, non-self-renewing
multipotent progenitors, CFU-GEMM, CFU-GM, BFU-E,
or CFU-Meg among these bone marrow compartments (Fig.
2). We were also not able to detect any intrinsic differences
among HSCs from different adult bone marrow compart-
ments in terms of phenotype (Suppl. Fig. 2 in Appendix A),
ability to reconstitute irradiated mice (Table 4), colony
formation in culture (Suppl. Table 2 in Appendix A), or
gene expression profile (Table 3; Fig. 3; Suppl. Table 1 in
Appendix A). These results indicate that HSCs from
spatially distinct hematopoietic compartments at the same
time during development do not exhibit intrinsic differences
in their properties.
Despite the lack of differences among spatially distinct
HSCs, there are clear differences among temporally distinct
HSCs. Previous studies have reported differences between
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(Hayakawa et al., 1985; Ikuta et al., 1990; Kantor et al.,
1992), cell cycle status (Morrison et al., 1995; Morrison and
Weissman, 1994), self-renewal potential (Lansdorp, 1995;
Morrison et al., 1995), genetic regulation (Park et al., 2003;
Puri and Bernstein, 2003), phenotype (Morrison et al.,
1995), and gene expression (Ivanova et al., 2002). Con-
sistent with this, we have readily detected differences in the
gene expression profiles of temporally distinct fetal and
adult HSCs (Table 3). We have previously observed that
neural crest stem cells from the gut undergo temporal
changes in developmental potential, mitotic activity, and
self-renewal potential that are similar to the temporal
changes observed in HSCs (Kruger et al., 2002). It is thus
interesting that HSCs and neural stem cells undergo
analogous changes over time while HSCs fail to exhibit
spatial differences analogous to those observed among
neural stem cells.
While definitive HSCs from late gestation and adulthood
do not differ between organs or bone marrow compartments,
HSCs may exhibit spatial diversity in other contexts. There
could be intrinsic differences among HSCs in different
microenvironments within individual bones or fetal organs.
We have only looked for differences among HSCs from
different regions of the hematopoietic system (different
bones or organs) that are analogous to the differences
observed among neural stem cells from different regions of
the nervous system. There could also be intrinsic differences
among spatially distinct HSCs in the primitive hemato-
poietic system, such as in the yolk sac, AGM, and liver
prior to E11. Finally, spatial differences could arise in
HSCs in response to injury: HSCs that participate in extra-
medullary hematopoiesis could adopt different properties
relative to bone marrow HSCs. We have restricted our
analysis to definitive HSCs during normal hematopoiesis
because these are the HSCs in which intrinsic differences
would influence homeostasis and fate determination during
normal development.
Several factors likely contribute to the failure of HSCs to
exhibit spatial differences. All definitive HSCs may descend
from a single population of progenitors that arises in the
dorsal aorta (Cumano et al., 1996; Medvinsky and Dzierzak,
1996) and that is therefore subject to a common patterning
environment during formation. If so, definitive HSCs would
differ from stem cells in other tissues partly because they
arise from a single location within the embryo rather than
different locations that are subject to different patterning
environments. Even so, HSCs must still avoid diversifying
in response to differences in local environments after they
subsequently migrate to different locations.
The recirculation of HSCs among different hematopoietic
compartments is another mechanism by which permanent
regional differences are precluded from arising between
HSCs (Wright et al., 2001). However, this recirculation does
not address whether HSCs undergo transient changes while
they are present in different hematopoietic compartments.Our failure to observe any phenotypic or functional differ-
ences between fetal liver HSCs and fetal spleen HSCs, or
between adult HSCs from different bones suggests that this
is not the case. The ability of HSCs to migrate through
different fetal and adult environments while avoiding even
transient changes in their properties is remarkable relative to
what is observed in other tissues like the nervous system
(Trainor and Krumlauf, 2000; Trainor et al., 2002).
Our data raise the possibility that stem cell niches (Calvi
et al., 2003; Zhang et al., 2003) insulate HSCs from regional
environmental differences. Further characterization of HSC
niches will be required to test whether this is one of their
functions. If so, HSC niches would fundamentally differ
from niches in other tissues that maintain stem cells while
permitting them to acquire regional identities. Even if this is
the case, HSCs would still be exposed to variable local
environments as they migrate between hematopoietic
compartments, and through non-hematopoietic tissues such
as the adult liver (Taniguchi et al., 1996) and skeletal muscle
(McKinney-Freeman et al., 2002). HSCs must therefore
possess at least some cell-autonomous mechanisms that
protect them from the influence of environmental signals
outside of the niche.
Why do HSCs avoid regional diversification while stem
cells in the nervous system depend on it? In the nervous
system, pathways that are permissive for the migration of
neural progenitors are spatially and temporally restricted,
and differentiated neural cells usually lack the ability to
migrate. In contrast, differentiated hematopoietic cells can
easily and dynamically migrate through the blood to almost
all other parts of the body. This allows the hematopoietic
system to achieve spatial diversity by regulating the homing
of mature cells rather than by creating regional differences
in stem cells. The restricted migratory capacity of neural
cells makes it necessary for them to differentiate closer to
the sites at which they function. Since neural diversity is
encoded by a combinatorial mechanism involving the
interaction of diverse types of stem cells with diverse local
environments (Bixby et al., 2002), the patterning of neural
stem cells to acquire regional identities (that confer
competence to acquire regional fates) enhances the gen-
eration of diversity. Moreover, immune system cells must be
dynamically reorganized to respond to pathogen challenges
throughout the body, while neuron maps must be stereo-
typed and relatively constant in order to process information
correctly. These may be some of the selective forces that
drove the evolution of mechanisms that permit the regional
diversification of stem cells in the nervous system and other
tissues, but not in hematopoiesis.
Apart from the implications of these observations for
understanding the evolution of organogenic mechanisms in
different tissues, our data make the point that not all
important regulatory mechanisms are conserved between
stem cells from different tissues. In addition to mechanisms
that are strikingly conserved between stem cells in different
tissues, there are also mechanisms that are strikingly
M.J. Kiel et al. / Developmental Biology 283 (2005) 29–3938different. Obviously, there must be many differences in the
regulation of stem cells from different tissues in order for
those tissues to acquire different forms, functions, and
maintenance strategies. The mechanistic differences
between stem cells are at least as important as the
similarities in order to understand the role of stem cells in
organogenesis and the origin of differences between tissues.Acknowledgments
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